Verrica Pharmaceuticals (VRCA)
(Delayed Data from NSDQ)
$2.08 USD
-0.22 (-9.57%)
Updated Sep 5, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.36 |
EPS Last Quarter | -0.31 |
Last EPS Surprise | 27.91% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.56 |
Next Year | -0.83 |
EPS (TTM) | -1.49 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 7.62M | 9.99M | 26.52M | 81.33M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 7.94M | 11.41M | 28.13M | 95.00M |
Low Estimate | 7.11M | 9.07M | 25.14M | 64.24M |
Year ago Sales | 2.92M | 1.99M | 5.12M | 26.52M |
Year over Year Growth Est. | 160.82% | 402.16% | 417.62% | 206.62% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.36 | -0.32 | -1.56 | -0.83 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.36 | -0.32 | -1.49 | NA |
High Estimate | -0.33 | -0.27 | -1.49 | -0.57 |
Low Estimate | -0.39 | -0.36 | -1.65 | -1.27 |
Year ago EPS | -0.32 | -0.48 | -1.14 | -1.56 |
Year over Year Growth Est. | -12.50% | 33.33% | -36.84% | 46.47% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.36 | -0.32 | -1.56 | -0.83 |
7 Days Ago | -0.36 | -0.32 | -1.56 | -0.83 |
30 Days Ago | -0.37 | -0.33 | -1.57 | -0.83 |
60 Days Ago | -0.37 | -0.33 | -1.57 | -0.83 |
90 Days Ago | -0.37 | -0.33 | -1.57 | -0.83 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.36 | -0.32 | -1.57 | -0.83 |
Zacks Consensus Estimate | -0.36 | -0.32 | -1.56 | -0.83 |
Earnings ESP | 0.00% | -1.05% | -0.97% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.31 | -0.38 | -0.48 | -0.32 | NA |
Estimate | -0.43 | -0.54 | -0.47 | -0.22 | NA |
Difference | 0.12 | 0.16 | -0.01 | -0.10 | 0.04 |
Surprise | 27.91% | 29.63% | -2.13% | -45.45% | 2.49% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more